1Kyprianou N,Tu H,Jacobs SC.Apoptotic versus proliferative activities in human prostate hyperplasia[].Human Pathology.1996
2Gavrieli Y,Sherman Y,Ben-Sasson SA.Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation[].The Journal of Cell Biology.1992
3McNeal JE.Normal histology of the prostate[].The American Journal of Surgical Pathology.1988
4Famswotth WE.Role of estrogen and SHBG in prostate physiology[].Prostate.1996
5Juniewicz PE,Berry SJ,Coffey DS,Strandberg JD,Ewing LL.The requirement of the testis in establishing the sensitivity of the canine prostate to develop benign prostatic hyperplasia[].Journal d Urologie.1994
7Isaacs JT.Antagonistic effect of androgen on prostatic cell death[].Prostate.1984
8Lee C,Sensibar JA,Dudek SM,Hipakka RA,Liao ST.Prostatic ductal system in rats: regional variation in morphological and functional activities[].Biology of Reproduction.1990
9Krieq M,Nass R,Tunn S.Effect of aging on endogenous level of 5a-dihydrotestosterone, testosterone, estradiol, and estrogen in epithelium and stroma of normal and hyperplastic human prostate[].Journal of Clinical Endocrinology Metabolism The.1993
10Isaacs JT,Furuya Y,Berges R.The role of androgen in the regulation of programmd cell death/apoptosis in normal and malignant prostatic tissue[].Seminars in Cancer Biology.1994
7Ozden C,Ozdal OL,Urgancioglu G,et al.The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia.European Urology,2007,51:199-203.
8HammarstenJB,Hogsted T,Holthuis N,et al.Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia.Prostate Cancer and Prostatic Diseases,1998,1:157-162.
9Xie LP,Bai Y,Zhang XZ,et al.Obesity and benign prostatic enlargement:A large observational study in China.Urology,2007,69:680-684.
